QVA149

 

Topic mentions per year

Topic mentions per year

2010-2017
05101520102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2014
2014
INTRODUCTION QVA149 is a novel, inhaled, once-daily dual bronchodilator containing a fixed-dose combination of the long-acting β2… (More)
Is this relevant?
2014
2014
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and glycopyrronium, on direct patient-reported… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2014
2014
BACKGROUND To further assess the safety profile of the fixed-dose combination of indacaterol and glycopyrronium (QVA149) and its… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND We evaluated the effect of dual, longacting inhaled bronchodilator treatment on exacerbations in patients with severe… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND QVA149 is an inhaled fixed-dose combination therapy under development for the treatment of chronic obstructive… (More)
Is this relevant?
2013
2013
BACKGROUND QVA149 is an inhaled, once-daily fixed-dose dual bronchodilator combination of the long-acting β2-agonist indacaterol… (More)
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 2
Is this relevant?
2010
2010
BACKGROUND This randomised, double-blind, placebo controlled, four-period crossover study assessed the efficacy and safety of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2010
2010
This study assessed the cardiovascular safety of QVA149, an inhaled, once daily, bronchodilator combination containing two 24… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?